These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 16552033)

  • 1. Infection with Plasmodium berghei boosts antibody responses primed by a DNA vaccine encoding gametocyte antigen Pbs48/45.
    Haddad D; Maciel J; Kumar N
    Infect Immun; 2006 Apr; 74(4):2043-51. PubMed ID: 16552033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccine.
    Kou X; Zheng W; Du F; Liu F; Wang M; Fan Q; Cui L; Luo E; Cao Y
    Parasit Vectors; 2016 Apr; 9():190. PubMed ID: 27038925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-investigation of the circumsporozoite protein-based induction of sterile immunity against Plasmodium berghei infection.
    Reed RC; Louis-Wileman V; Wells RL; Verheul AF; Hunter RL; Lal AA
    Vaccine; 1996 Jun; 14(8):828-36. PubMed ID: 8817831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus.
    Sedegah M; Weiss W; Sacci JB; Charoenvit Y; Hedstrom R; Gowda K; Majam VF; Tine J; Kumar S; Hobart P; Hoffman SL
    J Immunol; 2000 Jun; 164(11):5905-12. PubMed ID: 10820272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A blood stage fraction of Plasmodium berghei induces protective and long lasting immune response in BALB/c mice.
    Bagai U; Pawar A
    Parasitol Int; 2013 Jun; 62(3):329-36. PubMed ID: 23085043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites.
    Leitner WW; Seguin MC; Ballou WR; Seitz JP; Schultz AM; Sheehy MJ; Lyon JA
    J Immunol; 1997 Dec; 159(12):6112-9. PubMed ID: 9550412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.
    Sanchez GI; Sedegah M; Rogers WO; Jones TR; Sacci J; Witney A; Carucci DJ; Kumar N; Hoffman SL
    Infect Immun; 2001 Jun; 69(6):3897-905. PubMed ID: 11349057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Pb51 in Plasmodium berghei as a malaria vaccine candidate targeting both asexual erythrocytic proliferation and transmission.
    Wang J; Zheng W; Liu F; Wang Y; He Y; Zheng L; Fan Q; Luo E; Cao Y; Cui L
    Malar J; 2017 Nov; 16(1):458. PubMed ID: 29132428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Plasmodium berghei Pbg37 as Both a Pre- and Postfertilization Antigen with Transmission-Blocking Potential.
    Liu F; Li L; Zheng W; He Y; Wang Y; Zhu X; Tsuboi T; Cui L; Wang M; Cao Y
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment.
    Goodman AL; Forbes EK; Williams AR; Douglas AD; de Cassan SC; Bauza K; Biswas S; Dicks MD; Llewellyn D; Moore AC; Janse CJ; Franke-Fayard BM; Gilbert SC; Hill AV; Pleass RJ; Draper SJ
    Sci Rep; 2013; 3():1706. PubMed ID: 23609325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium berghei XAT: contribution of gammadelta T cells to host defense against infection with blood-stage nonlethal malaria parasite.
    Kobayashi F; Niikura M; Waki S; Matsui T; Fujino T; Tsuruhara T; Kamiya S
    Exp Parasitol; 2007 Dec; 117(4):368-75. PubMed ID: 17601562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate.
    Zheng W; Liu F; He Y; Liu Q; Humphreys GB; Tsuboi T; Fan Q; Luo E; Cao Y; Cui L
    Parasit Vectors; 2017 Jan; 10(1):8. PubMed ID: 28057055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy.
    Leitner WW; Bergmann-Leitner ES; Angov E
    Malar J; 2010 May; 9():145. PubMed ID: 20507620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.
    Gilbert SC; Schneider J; Plebanski M; Hannan CM; Blanchard TJ; Smith GL; Hill AV
    Biol Chem; 1999 Mar; 380(3):299-303. PubMed ID: 10223332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of homologous and heterologous antigen-delivery prime-boost strategy.
    Kongkasuriyachai D; Bartels-Andrews L; Stowers A; Collins WE; Sullivan J; Sattabongkot J; Torii M; Tsuboi T; Kumar N
    Vaccine; 2004 Aug; 22(23-24):3205-13. PubMed ID: 15297075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein.
    Weiss R; Leitner WW; Scheiblhofer S; Chen D; Bernhaupt A; Mostböck S; Thalhamer J; Lyon JA
    Infect Immun; 2000 Oct; 68(10):5914-9. PubMed ID: 10992502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective efficacy of MSP4/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA vaccine vector and vaccination protocol.
    Rainczuk A; Smooker PM; Kedzierski L; Black CG; Coppel RL; Spithill TW
    Vaccine; 2003 Jun; 21(21-22):3030-42. PubMed ID: 12798647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple antigen constructs (MACs): induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii.
    Reed RC; Louis-Wileman V; Cosmai EV; Fang S; Jue DL; Wohlhueter RM; Hunter RL; Lal AA
    Vaccine; 1997 Apr; 15(5):482-8. PubMed ID: 9160515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of immunogenicity of an oral Salmonella vaccine expressing recombinant Plasmodium berghei merozoite surface protein-1.
    Toebe CS; Clements JD; Cardenas L; Jennings GJ; Wiser MF
    Am J Trop Med Hyg; 1997 Feb; 56(2):192-9. PubMed ID: 9080880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Construction and expression of Plasmodium berghei chimeric protein in Pichia pastoris and its immunogenicity in mice].
    Cao Y; Zhang DM; Pan WQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Oct; 26(5):327-31. PubMed ID: 19157293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.